B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

P2RX4

MOLECULAR TARGET

purinergic receptor P2X 4

UniProt: Q99571NCBI Gene: 50253 compounds

P2RX4 (purinergic receptor P2X 4) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting P2RX4

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1paroxetine4.3980
2imd 03542.8316
3Adenosine Triphosphate1.795

About P2RX4 as a Drug Target

P2RX4 (purinergic receptor P2X 4) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented P2RX4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

P2RX4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.